Synopsys INC Form 4 insider transactions
NASDAQ
SNPS
Synopsys INCA leading simulation software company has finalized its merger, becoming a wholly-owned subsidiary of a major electronic design automation firm, leading to its delisting from Nasdaq.
NASDAQ
SNPS
Synopsys INCSynopsys, Inc. has successfully completed its acquisition of Ansys, Inc., creating a leader in engineering solutions and expanding its total addressable market to $31 billion.
NASDAQ
SNPS
Synopsys INCSynopsys, Inc. has received all necessary regulatory approvals to proceed with its acquisition of Ansys, Inc., with the transaction expected to close on or about July 17, 2025.
NASDAQ
SNPS
Synopsys INCSynopsys, Inc. has received all necessary regulatory approvals for its proposed acquisition of Ansys, Inc., with the transaction expected to close around July 17, 2025.
NASDAQ
SNPS
Synopsys INC425: Synopsys and Ansys Acquisition Faces Timing Adjustment Amidst Pending China Regulatory Approval
Synopsys and Ansys announced an update on their proposed acquisition, confirming all merger clearances received except for the final approval from China's State Administration for Market Regulation.
NASDAQ
SNPS
Synopsys INCSynopsys and Ansys announced significant progress on their proposed acquisition, having secured merger clearance in all jurisdictions except China, where final regulatory approval is now in an advanced stage.
NASDAQ
SNPS
Synopsys INCSynopsys Inc.'s Chief Revenue Officer, Richard S. Mahoney, engaged in pre-planned transactions on June 18, 2025, exercising stock options and selling common stock under a Rule 10b5-1 trading plan.
NASDAQ
SNPS
Synopsys INCSynopsys Inc.'s Chief Revenue Officer, Richard S. Mahoney, reported the vesting of 7,832 restricted stock units and a subsequent sale of 3,411 shares to cover tax obligations.
NASDAQ
SNPS
Synopsys INCForm 4: Synopsys CFO Shelagh Glaser Executes Stock Options and Sells Shares Under Pre-Arranged Trading Plan
Synopsys Inc.'s Chief Financial Officer, Shelagh Glaser, exercised stock options and subsequently sold a total of 7,310 shares of common stock on June 6, 2025, as part of a Rule 10b5-1 trading plan.
NASDAQ
SNPS
Synopsys INCSynopsys President and CEO Sassine Ghazi exercised stock options and subsequently sold 11,366 shares of common stock for approximately $457.93 per share, as part of a pre-arranged 10b5-1 trading plan.
NASDAQ
SNPS
Synopsys INCDirector John Schwarz reports acquisition of 491 shares of Synopsys common stock through an automatic award under the company's 2017 Non-Employee Directors Equity Incentive Plan.
NASDAQ
SNPS
Synopsys INCDirector Jeannine P. Sargent reports acquisition of common stock and disposal by a family trust.
NASDAQ
SNPS
Synopsys INCDirector Robert G. Painter reports acquiring and disposing of Synopsys Inc. common stock on April 10, 2025, according to a Form 4 filing.
NASDAQ
SNPS
Synopsys INCDirector Mercedes Johnson reported a transfer of Synopsys shares to a trust, along with an automatic award of shares under the company's equity incentive plan.
NASDAQ
SNPS
Synopsys INCDirector Bruce R. Chizen reported the acquisition of 491 shares of Synopsys Inc. common stock on April 10, 2025, through an automatic award under the company's 2017 Non-Employee Directors Equity Incentive Plan.
NASDAQ
SNPS
Synopsys INCDirector Janice Chaffin reports acquisition of 491 shares of Synopsys common stock through an automatic award under the company's equity incentive plan.
NASDAQ
SNPS
Synopsys INCDirector Luis Borgen reports acquisition of 491 shares and disposal of 1,833 shares of Synopsys common stock on April 10, 2025.
NASDAQ
SNPS
Synopsys INCSudhindra Kankanwadi, Chief Accounting Officer of Synopsys Inc., reports the vesting of restricted stock units and subsequent tax withholding.
NASDAQ
SNPS
Synopsys INCJohn F. Runkel Jr., GC & Corporate Secretary of Synopsys Inc., reports the vesting of restricted stock units and subsequent tax withholding.
NASDAQ
SNPS
Synopsys INCRichard Mahoney, Chief Revenue Officer of Synopsys Inc., reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to his beneficial ownership of company stock.
NASDAQ
SNPS
Synopsys INCSynopsys CFO Shelagh Glaser reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to her beneficial ownership of company stock.
NASDAQ
SNPS
Synopsys INCSynopsys CEO Sassine Ghazi reports the vesting of restricted stock units and associated tax withholding.
NASDAQ
SNPS
Synopsys INCAart de Geus, Executive Chair of Synopsys, reports the vesting of restricted stock units and associated tax withholding.
NASDAQ
SNPS
Synopsys INCAart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares on March 6, 2025, according to a Form 4 filing with the SEC.
NASDAQ
SNPS
Synopsys INCSynopsys announces that the U.K. Competition and Markets Authority (CMA) has cleared its proposed acquisition of Ansys in Phase 1, subject to previously announced divestitures, and anticipates closing the transaction in the first half of 2025.
NASDAQ
SNPS
Synopsys INCSudhindra Kankanwadi, Chief Accounting Officer of Synopsys Inc., acquired 25 shares of common stock through the company's Employee Stock Purchase Plan on February 28, 2025.
NASDAQ
SNPS
Synopsys INCRichard S. Mahoney, Chief Revenue Officer of Synopsys Inc., acquired 25 shares of common stock through the company's Employee Stock Purchase Plan on February 28, 2025.
NASDAQ
SNPS
Synopsys INCJohn F. Runkel Jr., GC & Corporate Secretary of Synopsys Inc., reports acquiring 25 shares of common stock through the company's Employee Stock Purchase Plan at a price of $388.688 per share.
NASDAQ
SNPS
Synopsys INCShelagh Glaser, CFO of Synopsys Inc, reports acquiring 32 shares of common stock through the company's Employee Stock Purchase Plan at a price of $306.867 per share.
NASDAQ
SNPS
Synopsys INCAart de Geus, Executive Chair of Synopsys Inc., reports acquiring 25 shares of common stock through the company's Employee Stock Purchase Plan.